Amgen's leukemia drug Blincyto infringes patents owned by Germany's Lindis Biotech, a Delaware federal jury said in a verdict ...

We recently compiled a list of the 10 Dogs of the Dow Dividend Stocks to Invest in. In this article, we are going to take a ...

Shares of Amgen Inc. AMGN slumped 0.21% to $265.95 Tuesday, on what proved to be an all-around dismal trading session for the ...

Viridian Therapeutics stock popped Monday after the company scored a win in thyroid eye disease, a condition that causes the ...

We recently compiled a list of the 12 Best Weight Loss Stocks to Buy According to Hedge Funds. In this article, we are going ...

The drug manufacturer Amgen announced Thursday it will invest another $1 billion and add 370 jobs to its future facility in ...

Amgen, a biotechnology company, announced last week that it will invest $1 billion in expanding its manufacturing facility in ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Biopharma company Amgen plans to add 370 jobs as part of a new, $1.02 billion investment in Holly Springs. It’s the latest move by the company to expand manufacturing capacity in the fast ...

U.S. drugmaker Amgen said on Thursday it will invest $1 billion towards a second drug substance manufacturing facility in ...

Amgen’s decision to locate – and now expand – in Holly Springs fortifies the town’s and state’s reputations as ...

Wells Fargo analyst Derek Archila maintained a Buy rating on Viridian Therapeutics (VRDN – Research Report) yesterday and set a price target of ...